Taurine inhibition of iron-stimulated catecholamine oxidation

Advances in Experimental Medicine and Biology

Volumn 442, Issue , 1998, Pages 155-162

  Dawson Jr , Ralph ^a   Tang, Elisa ^a   Shih, Debbie ^a   Hern, Hunter ^a   Hu, Ming ^a   Baker, Deron ^a   Eppler, Baerbel ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BETA ALANINE; CYSTEINE; CYSTINE; FERRIC CHLORIDE; GLUTATHIONE; HYPOTAURINE; IRON; LEVODOPA; LYSINE; METHIONINE; TAURINE;

ADULT; AGED; AMINO ACID METABOLISM; CATECHOLAMINE RELEASE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; IRON METABOLISM; LIPID PEROXIDATION; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0031837785     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-0117-0_20     Document Type: Conference Paper

References (26)

1. Aruoma, O.I., Halliwell, B., Hoey, B.M., and Butler, J., 1988, The antioxidant action of taurine, hypotaurine and their metabolic precursors, Biochem. J., 256:251-255.
2. Carney, J.M., Starke-Reed, P.E., Oliver, C.N., Landum, R.W., Cheng, M.S., Wu, J.F., and Floyd, R.A., 1991, Reversal of age-related increases in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tertbutyl-α-phenylnitrone, Proc. Natl. Acad. Sci., 88:3633-3636.
3. Cozzi, R., Ricordy, R., Bartolini, Ramadori, L., Perticone, P., and De Salvia, R., 1995, Taurine and ellagic acid: two differently-acting natural antioxidants, Environ. Mol. Mutagen., 26:248-254.
4. Dawson, R. and Wallace, D.R., 1992, Taurine content in tissues from aged Fischer 344 rats, Age, 15:73-81.
5. 1 cells, Renal Physiol. Biochem., 17:85-100.
6. Dawson, R., Eppler, B., Patterson, T.A., Shih, D., and Liu, S., 1996, The effects of taurine in a rodent model of aging, in Adv. Exp. Med. Biol. "Taurine 2 Basic and Clinical Aspects", Huxtable, R.J., Azuma, J., Kuriyama, K., Nakagawa, M., and Baba, A., eds., Plenum Press, Vol. 403, pp. 37-50.
7. Dean, R.T., Gieseg, S., and Davies, R.T., 1993, Reactive species and their accumulation on radical damaged proteins, Trends Biochem. Sci., 18:437-441.
8. Graham, D.G., Tiffany, S.M., Bell, W.R., and Gutknecht, W.F., 1978, Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro, Mol. Pharmacol., 14:644-653.
9. Han, S-K., Mytilineou, C., and Cohen, G., 1996, L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress, J. Neurochem., 66:501-510.
10. Huxtable, R.J., 1992, Physiological actions of taurine, Physiol. Rev., 72:101-163.
11. Kalyanaraman, B., Premovic, P.I., and Sealy, R.C., 1987, Semiquinone anion radicals from addition of amino acids, peptides, and proteins to quinones derived from oxidation of catechols and catecholamines, J. Biol Chem., 262:11080-11087.
12. Levine, R.L, Garland, D., Oliver, C.N., Amici, A.A., Climent, I., Lenz, A., Ahn, B., Shaltiel, S., and Stadtman, E.R., 1990, Determination of carbonyl content in oxidatively modified proteins, Meth. Enzymol., 186:464-478.
13. Miller, D.M., Buettner, G.R., and Aust, S.D., 1990, Transition metals as catalysts of "autoxidation" reactions, Free Rad. Biol. Med., 8:95-108.
14. Monks, T.J. and Lau, S.S., 1992, Toxicology of quinone-thioethers, Crit. Rev. Toxicol., 22:243-270.
15. Mosmann, T., 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Meth., 65:55-63.
16. Pardo, B., Mena, M.A., Casarejos, M.J., Paino, C.L., and De Yebenes, J.G., 1995, Toxic effects of 1-dopa on mesencephalic cell cultures: protection with antioxidants, Brain Res., 682:133-143.
17. Pasantes-Morales, H., Wright, C.E., and Gaull, G.E., 1985, Taurine protection of lymphoblastoid cells from iron-ascorbate induced damage, Biochem. Pharmacol., 34:2205-2207.
18. Spencer, J.P.E., Jenner, A., Aruoma, O.I., Evans, P.J., Kaur, H., Dexter, D.T., Jenner, P., Lees, A.J., Marsden, D.C., and Halliwell, B., 1994, Intense oxidative DNA damage promoted by 1-dopa and its metabolites implications for neurodegenerative disease, FEBS Lett., 353:246-250.
19. Stadtman, E.R. and Oliver, C.N., 1991, Metal-catalyzed oxidation of proteins, J. Biol. Chem., 266:2005-2008.
20. Tanaka, M., Sotomatsu, A., Kanai, H., and Hirai, S., 1991, Dopa and dopamine cause cultured neuronal death in the presence of iron, J. Neurol. Sci., 101:198-203.
21. Trachtman, H., Futterwiet, S., and Bienkowski, R.S., 1993, Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells, Biochem. Biophys. Res. Comm., 191:759-765.
22. Tse, D.C.S., McCreery, R.L., and Adams, R., 1976, Potential oxidative pathways of brain catecholamines, J. Med. Chem., 19:37-40.
23. Tyce, G.M. and Owen, C.A., 1973, The effect of L-3,4-dihydroxyphenylalanine administration on glucose metabolism in brain, J. Neurochem., 20:1563-1573.
24. Wills, E.D., 1987, Evaluation of lipid peroxidation in lipids and biological membranes, in "Biochemical Toxicology a Practical Approach" Snell, K. and Mullock, B., eds., IRL Press, Oxford, pp. 127-152.
25. Wright, C.E., Tallan, H.H., Lin, Y.Y., and Gaull, G.E., 1986, Taurine: biological update, Ann. Rev. Biochem., 55:427-453.
26. Youdim, M.B.H., Ben-Shachar, D., Eshel, G, Finberg, J.P.M., and Riederer, P., 1993, The neurotoxicity of iron and nitric oxide relevance to the etiology of Parkinson's disease, Adv. Neurol., 60:259-265.